Is Ultragenyx Pharmaceutical (RARE) Now Attractive After Recent 8.1% Weekly Share Price Jump
- If you are wondering whether Ultragenyx Pharmaceutical at US$23.15 is a bargain or a value trap, the key is understanding what the current price actually implies about the business.
- The stock has returned 8.1% over the last week and 2.4% over the last month, but is still showing a 1.9% decline year to date and a 31.7% decline over the last year, with even deeper 3 year and 5 year returns of 38.3% and 78.6% respectively.
- These moves sit against a backdrop of ongoing interest in rare disease treatments and the broader biotech sector, where sentiment can shift quickly as trial results, regulatory updates or partnership news emerge. Even without a single headline driving the latest 8.1% weekly gain, price action like this often reflects…
Source link
